- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 405/06
Total number of patents in this class: 2360
10-year publication summary
|
176
|
180
|
174
|
230
|
176
|
138
|
125
|
138
|
113
|
82
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20933 |
46 |
| Takeda Pharmaceutical Company Limited | 2713 |
41 |
| VALO Health, Inc. | 172 |
34 |
| Janssen Pharmaceutica N.V. | 3392 |
30 |
| Merck Sharp & Dohme LLC | 3748 |
30 |
| Eisai R&D Management Co., Ltd. | 1233 |
28 |
| Bristol-myers Squibb Company | 4898 |
26 |
| F. Hoffmann-La Roche AG | 7925 |
25 |
| Pulmocide Limited | 39 |
22 |
| Allergan, Inc. | 2349 |
20 |
| Shionogi & Co., Ltd. | 854 |
19 |
| AstraZeneca AB | 2909 |
18 |
| Orion Corporation | 643 |
18 |
| Boehringer Ingelheim International GmbH | 4650 |
17 |
| Temple University of the Commonwealth System of Higher Education | 615 |
16 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
15 |
| Bausch + Lomb Ireland Limited | 691 |
15 |
| Centre National de La Recherche Scientifique | 10418 |
14 |
| Abbvie Inc. | 1800 |
14 |
| Alkermes Pharma Ireland Limited | 269 |
14 |
| Other owners | 1898 |